Correspondence on 'Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement'

被引:5
作者
Banday, Aaqib Zaffar [1 ]
Jindal, Ankur Kumar [1 ]
Singh, Surjit [1 ]
机构
[1] Post Grad Inst Med Educ & Res, Dept Pediat, Allergy Immunol Unit, Chandigarh, India
关键词
autoimmunity; immune system diseases; inflammation; therapeutics; RUXOLITINIB; EFFICACY;
D O I
10.1136/annrheumdis-2021-219890
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
[41]   Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study [J].
Galloway, James ;
Barrett, Kevin ;
Irving, Peter ;
Khavandi, Kaivan ;
Nijher, Monica ;
Nicholson, Ruth ;
de Lusignan, Simon ;
Buch, Maya H. .
RMD OPEN, 2020, 6 (03)
[42]   Toward Telemonitoring in Immune-Mediated Inflammatory Diseases: Protocol for a Mixed Attention Model Study [J].
Novella-Navarro, Marta ;
Iniesta-Chamorro, Jose M. ;
Benavent, Diego ;
Bachiller-Corral, Javier ;
Calvo-Aranda, Enrique ;
Borrell, Helena ;
Berbel-Arcobe, Laura ;
Navarro-Compan, Victoria ;
Michelena, Xabier ;
Lojo-Oliveira, Leticia ;
Arroyo-Palomo, Jaime ;
Diaz-Almiron, Mariana ;
Garcia, Veronica Garcia ;
Monjo-Henry, Irene ;
Gonzalez, Claudia Maria Gomez ;
Gomez, Enrique J. ;
Balsa, Alejandro ;
Plasencia-Rodriguez, Chamaida .
JMIR RESEARCH PROTOCOLS, 2024, 13
[43]   T-cell exhaustion in immune-mediated inflammatory diseases: New implications for immunotherapy [J].
Gao, Zhanyan ;
Feng, Yang ;
Xu, Jinhua ;
Liang, Jun .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[44]   Microbiome research in autoimmune and immune-mediated inflammatory diseases: lessons, advances and unmet needs [J].
Scher, Jose U. ;
Nayak, Renuka ;
Clemente, Jose C. .
ANNALS OF THE RHEUMATIC DISEASES, 2024,
[45]   Evidence-base for the beneficial effect of nutraceuticals in canine dermatological immune-mediated inflammatory diseases - A literature review [J].
van Amersfort, Kelly ;
van der Lee, Annette ;
Hagen-Plantinga, Esther .
VETERINARY DERMATOLOGY, 2023, :266-283
[46]   Recombinant Zoster Vaccine Reduces All-Cause Mortality, But Not Major Adverse Cardiovascular Events, in Patients With Immune-Mediated Inflammatory Diseases Receiving Janus Kinase Inhibitors: A Large-Scale Real-World Retrospective Cohort Study [J].
Shih, Po-Cheng ;
Wang, Shiow-Ing ;
Leong, Pui-Ying ;
Huo, An-Ping ;
Wei, James Cheng-Chung .
JOURNAL OF MEDICAL VIROLOGY, 2025, 97 (03)
[47]   Janus kinase 2 (JAK2) inhibitors in the treatment of multiple myeloma: modulating the myeloma immune microenvironment [J].
Giles, Hannah ;
Pratt, Guy .
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (03) :420-422
[48]   Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects [J].
Song, Cong-ying ;
Xu, Ying-ge ;
Lu, Yuan-qiang .
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2020, 21 (04) :280-290
[49]   Is immunology doing well? A look at 100 immune-mediated inflammatory diseases for 100 years of the Journal [J].
Riminton, D. Sean .
IMMUNOLOGY AND CELL BIOLOGY, 2023, 101 (10) :896-901
[50]   Ω-3 Polyunsaturated Fatty Acids and Immune-Mediated Diseases: Inflammatory Bowel Disease and Rheumatoid Arthritis [J].
Ruggiero, C. ;
Lattanzio, F. ;
Lauretani, F. ;
Gasperini, B. ;
Andres-Lacueva, C. ;
Cherubini, A. .
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (36) :4135-4148